Jpmorgan Chase & CO Immuno Precise Antibodies Ltd. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
19Shares Held
1.9MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$841,8010.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny60.3KShares$32,5620.0% of portfolio
-
Bank Of Montreal Toronto, A657.8KShares$31,2150.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$27,3940.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$22,2480.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $13.4M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...